Stem Cell Transplantation Program at Dana-Farber/Brigham and Women’s Hospital

Stem Cell Transplantation Program at Dana-Farber/Brigham and Women’s Hospital

Joseph Antin, MD, Chief of the Medical Oncology Stem Cell Transplant Program, talks about the different types of stem cell transplant at Dana-Farber/Brigham and Women’s Cancer Center. The program has performed more than 7,100 stem cell and bone marrow transplants for the treatment of cancer since it began in 1972. 

Stem cell transplantation refers to a procedure where healthy stem cells are transplanted from one individual to another, or using an individual's own stem cells. Sources of stem cells include bone marrow, peripheral blood or umbilical cord blood. The procedure is sometimes referred to as a bone marrow transplant (BMT), peripheral blood stem cell transplant (PBSCT) or umbilical cord blood transplantation (UCBT), depending on the source of the cells that are transplanted.

In the earlier days of transplantation, the only acceptable donor was often a matched sibling, which left the change of finding a matched donor less than 25 percent. Stem cell transplant services now include autologous transplant, using your own stem cells; allogeneic transplant, using stem cells from a family member, unrelated matching donor, or umbilical cord blood; comprehensive services for related and unrelated donors; access to our extensive offering of specialized stem cell transplant clinical trials; and transplantation for adults over 60.

Learn more about Stem Cell Transplantation.

Read the Stem Cell Transplant Program video transcript

Presenter

Jospeh Antin, MDJospeh Antin, MD


View Full Video Close Window